Transcription factor REST dependent proteins are comparable between Down syndrome and control brains: challenging a...

Area of Science:

• Neuroscience
• Developmental Biology
• Genetics

Background:

• Previous studies indicated impaired RE-1-silencing transcription factor (REST) and its target genes in Down syndrome (DS) neuronal progenitor cells at the RNA level.
• The transition from RNA dysregulation to protein function in the brain remains complex and requires direct protein-level investigation.

Purpose of the Study:

• To investigate the protein expression levels of REST-dependent molecules in the developing brain of fetuses with Down syndrome.
• To determine if the previously observed RNA-level dysregulation translates to protein-level alterations in DS brains.

Main Methods:

• Analysis of fetal brain cortex samples from the early second trimester (18/19 weeks gestation) from both Down syndrome and control individuals.
• Immunoblotting was used to quantify protein levels of REST-dependent targets: synapsin I, brain-derived neurotrophic factor (BDNF), and neuronal growth-associated protein SCG10.
• Protein levels were normalized against housekeeping genes (glyceraldehyde-6-phosphate-dehydrogenase) and a neuronal density marker (neuron-specific enolase).

Main Results:

• Proteins including synapsin I, BDNF, and SCG10 were expressed comparably in fetal Down syndrome brains and control brains.
• Normalization against housekeeping genes and neuronal markers did not reveal significant differences between DS and control groups.
• The protein expression patterns did not support the hypothesis of REST system dysregulation at the protein level in the fetal DS brain.

Conclusions:

• This study does not confirm the REST-hypothesis at the protein level in the developing brain of fetuses with Down syndrome.
• Observed RNA-level changes in progenitor cells may not directly correlate with protein expression in the fetal brain cortex during early gestation.